Clinically, blood plasma or serum concentrations of both S1P and ApoM have been linked to human diseases such as sepsis, coronary artery disease (CAD), type I and II diabetes (T1/IID), systemic lupus erythematosus (SLE), and most recently, COVID (9–14). Here, APOM is linked to systemic lupus erythematosus.